Interviews with Cell Therapy Bioprocessing & Commercialization Keynote Speakers Marc Better and Julie Allickson

Register by Friday, September 4 and save $300 | Use code: XB15188BLOG

Gain a sneak peek of this year's upcoming Cell Therapy Bioprocessing & Commercialization meeting by listening to exclusive interviews between IBC Life Sciences and keynote speakers Dr. Marc Better (Kite Pharma) and Dr. Julie Allickson (Wake Forest School of Medicine).

Access the interviews here.

Register today to attend this year's meeting, held on September 30 - October 2, 2015 at the Hilton Alexandria Mark Center in Alexandria, VA. By attending in person, you will gain direct access to 80+ speaker presentations, 15+ exhibitors and Attendee Connect, the conference app and partnering tool. Visit the event website for full program details.

Rates increase this Friday, 9/4 – Save $300 now with the code XB15188BLOG

We hope to see you in Alexandria later this month!

Share this article with your social network, just click below to share now!

Share |

Hospira Joins Business of Biosimilars, Last Chance to Save is This Friday

At this year's 15th Annual Business of Biosimilars Conference, partner with 100+ movers and shakers in the biosimilars space including pharma, biotech, and legal experts at the leading forum to drive commercialization and market access of biosimilar drugs. By attending, you will learn how to:

• Identify business opportunities by analyzing the commercial realities of the market
• Increase market access by expanding your global footprint in the US, EU, and emerging regions via a new "Around the World in One Day" workshop
• Gain clarity from legal experts on state substitution laws, interchangeability, and takeways of high profile court cases
• Navigate through regulatory complexities, maximize market uptake, and drive commercial success of a biosimilar drug

Plus! We're excited to announce that Mohamed H. Ladha, Global Biologics Marketing, Global Pharmaceutical Marketing, Hospira has joined the Biosimilars speaker faculty. Hear from him and other industry experts in the below panel:

Looking at the Commercial Realities of the Biosimilar Market

• •  
  Moderator: John J. Lewis, Senior Vice President, Policy & Public Affairs,           Association of Clinical Research Organizations
• •  
  Panelists:
• - Giles Somers, Lead Analyst, Generics and Biosimilars, Datamonitor
• - Carsten Brockmeyer, CEO, Formycon AG
• - Mohamed H. Ladha, Global Biologics Marketing, Global Pharmaceutical Marketing, Hospira

Don't miss out on the opportunity to gain a 360 degree view on regulatory complexities, policy adoption, globalization and commercialization of the biosimilars industry. Download the brochure today to see how you can capitalize on the expected growth in the biologic medicines market.

Don't forget! This Friday, 9/12 is your last chance to SAVE $200! PLUS, you can save an extra $100 as a reader of this blog for a total of $300.  Register here and use code XP1986BLOG.

Follow us on Twitter: @FutureOfBiopharma & @Biosimilars
Join us on LinkedIn

Share this article with your social network, just click below to share now!

Share |